ANT Neuro announces cooperation with MAG & More in high-performance rTMS stimulators

ENSCHEDE, Netherlands - April 6, 2016 - PRLog -- ANT Neuro b.v., part of neuromotion b.v., is pleased to announce its cooperation with MAG & More GmbH in offering high performance, top of the range navigated TMS solutions for the advanced applications in research and clinical care.

This joint effort enables ANT to provide users with high-performance Transcranial Magnetic Stimulation (TMS) that complement ANT's navigated rTMS solutions range. The cooperation with MAG & More GmbH coincides with the upcoming release of ANT's visor2™ST complete navigated rTMS solution.

TMS is a non-invasive and painless method used to modulate neuronal activity in selected brain areas using short magnetic pulses. TMS neuromodulation with single-pulse or repetitive TMS (rTMS) is increasingly used in neuroscience as well as in treatment of psychiatric disorders such as depression and stroke. The combination of TMS and latest 3D neuronavigation technology makes this technique most attractive for routine clinical use.

"We are convinced this cooperation will benefit both parties in accelerating the development of new rTMS applications that meet even most advanced requirements in neuroscience and clinical use" said Wim Roojiers, CEO of ANT Neuro. "To integrate TMS stimulators into our product offering is a natural step towards achieving this goal and will advance our leading position in the market" said Frank Zanow, CEO of neuromotion.

Kerstin Häringer, founder and CEO of MAG & More GmbH: "Our company has a long history in repetitive magnetic stimulation and we have been continuously improving this technology to help clinicians". Christian Hirschbeck, CEO of MAG & More GmbH: "We are excited to combine our state of the art rTMS stimulators with the latest advances in neuronavigation and functional mapping offered by ANT Neuro with the visor2 range of solutions. This opens new potential fields of application for our PowerMAG TMS stimulators such as non-invasive pre-surgical functional mapping".

For more information about ANT's new visor2 navigated rTMS solutions please visit the ANT Neuro web site at www.ant-neuro.com. For more information about MAG & More´s rTMS technology please visit the MAG & More website at www.magandmore.com.


Media contacts

Wim Rooijers, CEO at ANT Neuro, marketing@ant-neuro.com, Tel. +31 (0) 53 436 5175.
Christian Hirschbeck, CEO at MAG & More GmbH, contact@magandmore.com, Tel. +49 (0)89 2018 5248.

About ANT Neuro b.v.

ANT Neuro is a Dutch corporation that specializes high-performance products for neuroscience, neurodiagnostics and neuromodulation. Applications apply to EEG, EMG, MRI, TMS and MEG technology. The company was established in 1997 as a spin-off company of The University of Twente, in Enschede and has now offices in the Netherlands, UK, Germany, USA and China. ANT Neuro is member of the neuromotion group. For more information, please visit www.ant-neuro.com.

About MAG & More GmbH

MAG & More is a privately owned German company that has focused on the production of magnetic stimulators and coils for almost twenty years. It specializes in research and development of cutting-edge technologies in the field of neuromodulation. The products are manufactured according to strict medical guidelines and are used worldwide in hospitals and private practices for research and therapy. For more information, please visit: www.magandmore.com